The Marriott Executive Apartments Manama and Residence Inn by Marriott Manama Juffair in Bahrain participated in a walkathon to raise awareness about diabetes in the kingdom.
Organised by Al Rashid Group, the "Walk-a-thon fo
The cases of type 2 diabetes continue to soar in the Middle East and North Africa (Mena) region, where around one in every ten adults live with diabetes, according to recent data.
The International Diabetes Federation’s new
Diabetes could lead to various sight problems or even lead to permanent blindness, warned Dr Madhav Rao, consultant ophthalmologist / vitreo-retinal surgeon at Abu Dhabi’s tertiary healthcare provider, Burjeel Hospital.
An average 20 per cent of the GCC population and nearly 19 per cent of the UAE population now live with diabetes, with a marked increase in type II diagnoses, according to latest figures by the International Diabetes Federation (IDF).
Royal College of Surgeons in Ireland (RCSI) has signed a deal with the Bahrain Diabetes Society to allow the continued operation of the Paediatric Mobile Diabetes Unit in the kingdom.
It was signed between Sheikh Mohammed bin Abdu
Bahrain has one of the highest rates of diabetes prevalence in the world, said its Health Ministry.
According to new figures released by the ministry yesterday (August 17), 15.4 per cent of Bahrainis aged over 20 suffer from diabetes, s
Eye experts in Dubai have warned about the rising incidence of cataracts in the GCC’s young by ageing population, especially among the large diabetic community.
Cataracts are the leading cause of blindnes
Saudi medical experts are meeting over a speaker tour across the kingdom, sharing the best practices in the diagnosis, treatment, and prevention of diabetes.
The tour featuring professional speakers, which recently took place in J
Bahrain will slash prices of medicines used to treat diabetes, blood and heart diseases by 50 per cent by the middle of next month, said a top official.
Prices will also be reduced for 1,800 categories of drugs in the first phase,
The US Food and Drug Administration approved GlaxoSmithKline's Tanzeum injection for treating adults with type 2 diabetes, in combination with diet and exercise.
Tanzeum will carry a warning on its label that tumors of the thy